95 related articles for article (PubMed ID: 3842696)
21. Antitumor antibiotics and low molecular weight immunomodifiers of microbial origin.
Umezawa H
Cancer Treat Rep; 1984 Jan; 68(1):137-44. PubMed ID: 6692425
[TBL] [Abstract][Full Text] [Related]
22. [Phase I study of forphenicinol, a new biological response modifier].
Terakado T; Saito K; Tajima K; Miyasato H; Suzuki T; Ikeda S
Gan To Kagaku Ryoho; 1983 Nov; 10(11):2309-17. PubMed ID: 6639093
[TBL] [Abstract][Full Text] [Related]
23. Bestatin, an aminopeptidase inhibitor with a multi-pharmacological function.
Mathé G
Biomed Pharmacother; 1991; 45(2-3):49-54. PubMed ID: 1912369
[TBL] [Abstract][Full Text] [Related]
24. Bestatin treatment and the peripheral lymphocyte population in cancer patients.
Blomgren H; Strender LE; Edsmyr F
Recent Results Cancer Res; 1980; 75():133-8. PubMed ID: 7232824
[TBL] [Abstract][Full Text] [Related]
25. [Immunotherapy with bestatin for acute non-lymphocytic leukemia (ANLL) in adults].
Kurita S; Ota K; Yamada K; Massaoka T; Uzuka Y; Ogawa N
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2742-50. PubMed ID: 6508324
[TBL] [Abstract][Full Text] [Related]
26. Low-molecular weight immunomodulators produced by microorganisms.
Umezawa H
Biotechnol Bioeng; 1980; 22 Suppl 1():99-110. PubMed ID: 6968594
[No Abstract] [Full Text] [Related]
27. Inhibition of tumor invasion and extracellular matrix degradation by ubenimex (bestatin).
Yoneda J; Saiki I; Fujii H; Abe F; Kojima Y; Azuma I
Clin Exp Metastasis; 1992 Jan; 10(1):49-59. PubMed ID: 1733647
[TBL] [Abstract][Full Text] [Related]
28. Immunopotentiation in infectious disease, I. Effect of bestatin on the immune response.
Ormrod DJ; Cawley S; Miller TE
Chemioterapia; 1985 Aug; 4(4):313-23. PubMed ID: 3876888
[TBL] [Abstract][Full Text] [Related]
29. Bestatin, an aminopeptidase B inhibitor, selectively reduces alcohol intake in rats.
Szczepanska R; Grupp LA
Alcohol Clin Exp Res; 1993 Apr; 17(2):434-7. PubMed ID: 8488990
[TBL] [Abstract][Full Text] [Related]
30. [Aminopeptidase inhibitor Bestatin induces HL-60 cell apoptosis through activating caspase 3].
Lin M; He J; Cai Z; Qian W
Zhonghua Xue Ye Xue Za Zhi; 2001 Jul; 22(7):348-50. PubMed ID: 11877095
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of fiber cell globulization and hyperglycemia-induced lens opacification by aminopeptidase inhibitor bestatin.
Chandra D; Ramana KV; Wang L; Christensen BN; Bhatnagar A; Srivastava SK
Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2285-92. PubMed ID: 12091429
[TBL] [Abstract][Full Text] [Related]
32. Induction of DNA polymerase alpha and terminal deoxynucleotidyl transferase in the human lymphoblastoid cell line Molt-4 by the immunomodulator bestatin.
Leyhausen G; Dippold W; Zahn RK; Meyer zum Büschenfelde KH; Umezawa H; Müller WE
Immunopharmacology; 1984 Jun; 7(3-4):151-7. PubMed ID: 6590537
[TBL] [Abstract][Full Text] [Related]
33. [Recovery from cyclophosphamide-induced myelosuppression accelerated by bestatin].
Uchida K; Kohi F; Yorimitsu S; Takahashi I; Kitajima K; Kimura I
Gan To Kagaku Ryoho; 1982 Feb; 9(2):220-4. PubMed ID: 7184398
[TBL] [Abstract][Full Text] [Related]
34. Effect of forphenicinol on the production of Ia-positive macrophages in mice with or without L1210 leukemia and on the growth of L1210 in immunized mice.
Okura A; Arakawa H; Yoshinari T; Naito K; Ishizuka M; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1986 Apr; 39(4):575-80. PubMed ID: 3458691
[TBL] [Abstract][Full Text] [Related]
35. Immunological and haematological monitoring in bladder cancer patients receiving adjuvant bestatin treatment following radiation therapy. A prospective randomized trial.
Blomgren H; Edsmyr F; Esposti PL; Näslund I
Biomed Pharmacother; 1984; 38(3):143-9. PubMed ID: 6383491
[TBL] [Abstract][Full Text] [Related]
36. Pharmacological role and degradation processes of neuromedin N in the gastrointestinal tract: an in vitro and in vivo study.
Barelli H; Woskowska Z; Cipris S; Fox-Threlkeld JE; Daniel EE; Vincent JP; Checler F
J Pharmacol Exp Ther; 1995 Dec; 275(3):1300-7. PubMed ID: 8531096
[TBL] [Abstract][Full Text] [Related]
37. [Phase III study of bestatin in patients with malignant skin tumors. (1) Malignant melanoma].
Ikeda S; Ishihara K; Taguchi G
Gan To Kagaku Ryoho; 1985 Jan; 12(1):77-85. PubMed ID: 3881086
[TBL] [Abstract][Full Text] [Related]
38. Small molecular microbial products enhancing immune response.
Umezawa H
Antibiot Chemother (1971); 1978; 24():9-18. PubMed ID: 655681
[TBL] [Abstract][Full Text] [Related]
39. Simultaneous modulation of transport and metabolism of acyclovir prodrugs across rabbit cornea: An approach involving enzyme inhibitors.
Katragadda S; Talluri RS; Mitra AK
Int J Pharm; 2006 Aug; 320(1-2):104-13. PubMed ID: 16720085
[TBL] [Abstract][Full Text] [Related]
40. Different enzymatic oscillations in vivo caused by the stereoisomers of an aminopeptidase inhibitor, bestatin.
Aoyagi T; Wada T; Yamamoto K; Kojima F; Nagai M; Harada S; Umezawa H
J Appl Biochem; 1984 Aug; 6(4):212-21. PubMed ID: 6520072
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
